Reassessment of the benefit/risk-ratio of selective COX-2-inhibitors. Swiss Med Wkly [Internet]. 2005 Mar. 26 [cited 2025 Nov. 4];135(1112):166-. Available from: https://smw.ch/index.php/smw/article/view/474